Gene · 6143
Papers1,583
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,583
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome analysis of six tissues obtained post-mortem from sepsis patients. | J Cell Mol Med | 2023 | 37731199 | PubTator, text mining | PubMed |
| ER-trafficking triggers NRF1 ubiquitination to promote its proteolytic activation. | iScience | 2023 | 37720101 | PubTator, text mining | PubMed |
| Comprehensive analysis of circulating cell-free RNAs in blood for diagnosing non-small cell lung cancer. | Comput Struct Biotechnol J | 2023 | 37692082 | PubTator, text mining | PubMed |
| Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients. | Int J Mol Sci | 2023 | 37685851 | PubTator, text mining | PubMed |
| INPP5E regulates CD3ζ enrichment at the immune synapse by phosphoinositide distribution control. | Commun Biol | 2023 | 37670137 | PubTator, text mining | PubMed |
| Interaction of Orexin and Bone Morphogenetic Proteins in Steroidogenesis by Human Adrenocortical Cells. | Int J Mol Sci | 2023 | 37628739 | PubTator, text mining | PubMed |
| Dbx2, an Aging-Related Homeobox Gene, Inhibits the Proliferation of Adult Neural Progenitors. | Stem Cell Rev Rep | 2023 | 37605090 | PubTator, text mining | PubMed |
| Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy. | Cell Genom | 2023 | 37601967 | PubTator, text mining | PubMed |
| Human granzyme B regulatory B cells prevent effector CD4+CD25- T cell proliferation through a mechanism dependent from lymphotoxin alpha. | Front Immunol | 2023 | 37588598 | PubTator, text mining | PubMed |
| Treating solid tumors with TCR-based chimeric antigen receptor targeting extra domain B-containing fibronectin. | J Immunother Cancer | 2023 | 37586774 | PubTator, text mining | PubMed |
| Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma. | Transl Lung Cancer Res | 2023 | 37577299 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning Model. | Int J Mol Sci | 2023 | 37569808 | PubTator, text mining | PubMed |
| A comprehensive analysis of biomarkers associated with synovitis and chondrocyte apoptosis in osteoarthritis. | Front Immunol | 2023 | 37545537 | PubTator, text mining | PubMed |
| Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders. | Front Endocrinol (Lausanne) | 2023 | 37529599 | PubTator, text mining | PubMed |
| Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells. | Int J Mol Sci | 2023 | 37511368 | PubTator, text mining | PubMed |
| A single nuclei atlas of aging human abdominal subcutaneous white adipose tissue. | Res Sq | 2023 | 37503028 | PubTator, text mining | PubMed |
| Cuproptosis-related risk score based on machine learning algorithm predicts prognosis and characterizes tumor microenvironment in head and neck squamous carcinomas. | Sci Rep | 2023 | 37481622 | PubTator, text mining | PubMed |
| Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis. | Front Immunol | 2023 | 37457712 | PubTator, text mining | PubMed |
| Exploring potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy. | Front Med (Lausanne) | 2023 | 37457560 | PubTator, text mining | PubMed |
| Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks. | Cell Death Dis | 2023 | 37438342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6143/papers?page=4